Trials / Completed
CompletedNCT02608801
Prediction and Secondary Prevention of Fractures
Prediction and Secondary Preventing of Fractures in a Norwegian Population. A Substudy of Norwegian Capture the Fracture Initiative
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 840 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate patient related factors that contribute to increased risk of recurrent fractures and to investigate patient adherence to prescribed anti-osteoporotic drugs.
Detailed description
A standardized treatment program of osteoporosis will be introduced successively at 7 hospitals in Norway from April 2015 to January 2016. This Project is named NoFRACT (Norwegian Capture the Fracture Initiative https://clinicaltrials.gov/show/NCT02536898). Patients above 50 years of age, who recently have suffered a fragility fracture, will be offered examination of osteoporosis and treatment if indicated. Some of these patients will be asked to participate in this consent-based sub-study (NoFRACTsub). At baseline, the patients will be asked to answer a questionnaire, collect blood-sample for to outline possible causes for osteoporosis, in addition to Dual X-Ray Apsopiometry (DXA) scan including bone mineral density(BMD), trabecular bone score(TBS) and vertebral fracture assessment (VFA). At 1-year follow-up there will be a brief questionnaire and measuring of BTM. At 2-year follow-up there will be a brief questionnaire in addition to repeated measurement of DXA including BMD, TBS and VFA. All data will be stored securly at the designated server at the University of Oslo, Service of sensitive data, TSD.
Conditions
- Osteoporotic Fractures
- Hip Fractures
- Wrist Fractures
- Ankle Fractures
- Vertebral Compression Fractures
- Humeral Fractures, Proximal
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-12-31
- Completion
- 2019-12-31
- First posted
- 2015-11-20
- Last updated
- 2020-03-04
Locations
6 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT02608801. Inclusion in this directory is not an endorsement.